Skip to content

The Oncology Institute, Inc. TOI Specialty pharmacy — Total Assets

Other segment segments

Patient services
$83.12M+26.4%
Clinical trials & other
$6.04M-24.5%

Similar metrics at other companies

Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Total Assets
$41.03B+14.8%
Stepan logo
SCLSpecialty Products — Total Assets
$83.23M+10.0%
Balchem logo
BCPCSpecialty Products — Total Assets
$169.77M+1.8%
Ashland logo
ASHSpecialty Additives — Total Assets
$988M-27.1%
Standex International logo
SXISpecialty Solutions Group — Total Assets
$40.31M-2.6%
Tutor Perini logo
TPCSpecialty Contractors — Total Assets
$421.83M+101%

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s specialty pharmacy — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s specialty pharmacy — total assets?
The Oncology Institute, Inc. (TOI) reported specialty pharmacy — total assets of $29.14M in Q1 2026.
What does specialty pharmacy — total assets mean?
This represents the aggregate value of all resources, including inventory, equipment, and receivables, controlled by the specialty pharmacy segment. It serves as a measure of the capital base deployed to generate segment revenue and support pharmacy operations. Analyzing this metric allows for the assessment of asset utilization and the scale of the segment's footprint.